Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.43 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 4/20 | 0.42 |
| ▸ | TKT | P29401 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6259547 | 0.79 | ALDH1A1 (0.60) | ALDH1A1KMT2ALMNAKDM4EMEN1 | |
| Pyrophosphoric Acid SCHEMBL5922584 | 0.79 | TDP1 (0.58) | LMNACYP2C19TDP1TKT | |
| SCHEMBL5165127 | 0.79 | TDP1 (0.39) | LMNATDP1TKT | |
| Phosphoric Acid SCHEMBL459429 | 0.78 | ALDH1A1 (0.55) | ALDH1A1KMT2ALMNAKDM4EMEN1 | |
| SCHEMBL850696 | 0.78 | ALDH1A1 (0.55) | ALDH1A1KMT2ALMNAKDM4EMEN1 | |
| Iodide SCHEMBL6303658 | 0.78 | ALDH1A1 (0.58) | ALDH1A1KMT2ALMNAKDM4EMEN1 | |
| SCHEMBL13176554 | 0.77 | ALDH1A1 (0.53) | ALDH1A1KMT2ALMNAKDM4EMEN1 | |
| SCHEMBL891367 | 0.75 | ALDH1A1 (0.59) | ALDH1A1KMT2ALMNAKDM4EMEN1 | |
| SCHEMBL9985419 | 0.75 | ALDH1A1 (0.59) | ALDH1A1KMT2ALMNAKDM4EMEN1 | |
| SCHEMBL28249445 | 0.74 | ALDH1A1 (0.58) | ALDH1A1KMT2ALMNAKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022411-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | BIOSYNTIA APS (DK) | 2026-01-22 | — | — | US | claimed |
| EP-4555076-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | Biosyntia ApS (DK) | 2025-05-21 | — | — | EP | claimed |
| WO-2024013212-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | BIOSYNTIA APS (DK) | 2024-01-18 | — | — | WO | claimed |
| US-20040006040-A1 | Method for the identification and treatment of pathogenic microorganism infections by inhibiting one or more enzymes in an essential metabolic pathway and compounds and pharmaceutical compositions useful therefor | PYRO PHARMACEUTICALS, INC. | 2004-01-08 | — | — | US | claimed |
| US-20240368659-A1 | MICROBIAL CELL FACTORIES PRODUCING VITAMIN B COMPOUNDS | BIOSYNTIA APS (DK) | 2024-11-07 | — | — | US | disclosed |
| EP-4370653-A2 | MICROBIAL CELL FACTORIES PRODUCING VITAMIN B COMPOUNDS | Biosyntia ApS (DK) | 2024-05-22 | — | — | EP | disclosed |
| CN-117705756-A | Terahertz near-field scanning system based on electric control optical sampling and light guide microprobe | 天津大学 | 2024-03-15 | — | — | CN | disclosed |
| US-11851461-B2 | Cell factory having improved iron-sulfur cluster delivery | BIOSYNTIA APS (DK) | 2023-12-26 | — | — | US | disclosed |
| US-20230192778-A1 | CELL FACTORY HAVING IMPROVED IRON-SULFUR CLUSTER DELIVERY | BIOSYNTIA APS (DK) | 2023-06-22 | — | — | US | disclosed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| WO-2023285585-A2 | MICROBIAL CELL FACTORIES PRODUCING VITAMIN B COMPOUNDS | BIOSYNTIA APS (DK) | 2023-01-19 | — | — | WO | disclosed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| EP-1651780-A2 | THIAMIN PRODUCTION BY FERMENTATION | DSM IP Assets B.V. (NL) | 2006-05-03 | — | — | EP | disclosed |
| EP-1490678-A2 | COMPOSITIONS AND METHODS FOR MODELING BACILLUS SUBTILIS METABOLISM | Genomatica, Inc. (US) | 2004-12-29 | — | — | EP | disclosed |
| WO-2004106557-A2 | THIAMIN PRODUCTION BY FERMENTATION | DSM IP ASSETS B.V. (NL) | 2004-12-09 | — | — | WO | disclosed |
| WO-2004099404-A2 | BIOINFORMATIC METHOD FOR PREDICTING FUNCTIONAL EQUIVALENCE BETWEEN BIOLOGICAL SEQUENCES | EUROPEAN MOLECULAR BIOLOGY LABORATORY (DE) | 2004-11-18 | — | — | WO | disclosed |
| WO-2003081207-A2 | COMPOSITIONS AND METHODS FOR MODELING BACILLUS SUBTILIS METABOLISM | GENOMATICA, INC. (US) | 2003-10-02 | — | — | WO | disclosed |
| EP-1093520-A1 | HMP-P KINASE AND TMP-PPASE FROM ARABIDOPSIS THALIANA AND THEIR USE IN HERBICIDE SCREENING | Syngenta Participations AG (CH) | 2001-04-25 | — | — | EP | disclosed |
| EP-1059354-A2 | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby | Ceres Incorporated (US) | 2000-12-13 | — | — | EP | disclosed |
| WO-2000000623-A1 | HMP-P KINASE AND TMP-PPASE FROM ARABIDOPSIS THALIANA AND THEIR USE IN HERBICIDE SCREENING | SYNGENTA PARTICIPATIONS AG (CH) | 2000-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040006040-A1 | Method for the identification and treatment of pathogenic microorganism infections by inhibiting one or more enzymes in an essential metabolic pathway and compounds and pharmaceutical compositions useful therefor | CYP51A1, ME1, BPGM | ALDH1A1 486/4885KMT2A 3172/4885LMNA 3872/4885 |
| US-20260022411-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | AHCY, SHMT1, MTHFD1 | ALDH1A1 624/4885KMT2A 2677/4885LMNA 4260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.